Lundbeckfonden Ventures Portfolio News

Find latest news about a company and their developments

This is press releases sent out by the companies. Questions and comments should be send to the company directly.

scPharmaceuticals

3 July 2019

scPharmaceuticals Announces FUROSCIX® NDA Resubmission
Sanifit

26 June 2019

Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
Atox Bio

19 June 2019

Atox Bio Announces Exercise by BARDA of Next Option Period to Support Continued Development of Reltecimod for NSTI
Reneo Pharmaceuticals

20 May 2019

Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
BONESUPPORT

14 May 2019

BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB ON 14 MAY 2019
Acacia Pharma

10 May 2019

Acacia Pharma Group PLC – Acacia Pharma’s BARHEMSYS Significantly Improves Post-operative Nausea & Vomiting (PONV) in Rescue Treatment of Ambulatory Patients
Acacia Pharma

7 May 2019

ACACIA PHARMA: NOTICE OF ANNUAL GENERAL MEETING
BONESUPPORT

2 May 2019

BONESUPPORT HOLDING AB (publ) – Published Q1 2019 Interim report
Acacia Pharma

25 April 2019

ACACIA PHARMA ANNOUNCES POSITIVE PHASE 3 BARHEMSYS® RESCUE TREATMENT DATA TO BE PRESENTED AT THE ANNUAL CONGRESS OF ENHANCED RECOVERY AND PERIOPERATIVE MEDICINE
BONESUPPORT

25 April 2019

BONESUPPORT HOLDING AB (publ) – Q1 2019 Interim Report – invitation to conference call and webcast
BONESUPPORT

24 April 2019

BONESUPPORT™ – Change in the management team
BONESUPPORT

17 April 2019

BONESUPPORT HOLDING AB (publ) publishes Annual Report 2018
BONESUPPORT

16 April 2019

BONESUPPORT will publish quarterly report earlier than previously communicated
BONESUPPORT

10 April 2019

ACTIVE REMODELING OF CERAMENT® INTO HUMAN BONE CONFIRMED IN UK STUDY
Auro Biosciences

2 April 2019

Aura Biosciences Completes $40 Million Series D Financing
BONESUPPORT

29 March 2019

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
Psioxis Therapeutics LTD.

25 March 2019

PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment
Enterome

20 March 2019

Enterome announces research collaboration with renowned US Cancer Institute focused on new microbiome-derived cancer immunotherapy
Spero Therapeutics

19 March 2019

Spero Announces Appointment of Cynthia Smith to its Board of Directors
BONESUPPORT

13 March 2019

BONESUPPORT™ LAUNCHING A NEW PRODUCT – BONIFY™ – US PRODUCT PORTFOLIO EXPANSION
Sanifit

4 March 2019

Data from SNF472 Phase 1b Clinical Trial published in British Journal of Clinical Pharmacology
BONESUPPORT

1 March 2019

Issue and repurchase of series C shares for share saving programs
Acacia Pharma

27 February 2019

Acacia Pharma Group PLC – Acacia Pharma Group plc Results For The Year Ended 31 December 2018
BONESUPPORT

27 February 2019

BONESUPPORT HOLDING AB (publ) – Full Year Report 2018
Acacia Pharma

26 February 2019

Acacia Pharma Group PLC – Acacia Pharma to Announce Its Results For the Full Year 2018 on Wednesday 27 February
Spero Therapeutics

26 February 2019

Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR720
BONESUPPORT

22 February 2019

BONESUPPORT – Publication of a clinical study highlighting Vancomycin release from CERAMENT® V in major hip surgery
BONESUPPORT

20 February 2019

BONESUPPORT HOLDING AB (publ) – Invitation to conference call in connection of the Full Year Report 2018
Atox Bio

18 February 2019

Atox Bio Announces Appointment of Robert Greif as Chief Commercial Officer
BONESUPPORT

8 February 2019

BONESUPPORT – Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT® in large bone defects